MafA and MafB activity in pancreatic β cells

Trends in Endocrinology and Metabolism

Volumn 22, Issue 9, 2011, Pages 364-373

  Hang, Yan ^a   Stein, Roland ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR MAFA; TRANSCRIPTION FACTOR MAFB;

CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; DIABETES MELLITUS; DNA BINDING; EMBRYONIC STEM CELL; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMALS; EMBRYONIC STEM CELLS; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; MAF TRANSCRIPTION FACTORS, LARGE; MAFB TRANSCRIPTION FACTOR; MICE; MODELS, ANIMAL;

EID: 80052381881     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.05.003     Document Type: Review

References (120)

1. Shapiro A.M., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 2000, 343:230-238.
2. Ackermann A.M., Gannon M. Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J. Mol. Endocrinol. 2007, 38:193-206.
3. Finegood D.T., et al. Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 1995, 44:249-256.
4. Teta M., et al. Very slow turnover of beta-cells in aged adult mice. Diabetes 2005, 54:2557-2567.
5. Alonso L.C., et al. Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes 2007, 56:1792-1801.
6. Miettinen P.J., et al. Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes 2006, 55:3299-3308.
7. Dor Y., et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
8. Flier S.N., et al. Evidence for a circulating islet cell growth factor in insulin-resistant states. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:7475-7480.
9. Butler A.E., et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
10. Menge B.A., et al. Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. Diabetes 2008, 57:142-149.
11. Georgia S., Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J. Clin. Invest. 2004, 114:963-968.
12. Kushner J.A., et al. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol. Cell. Biol. 2005, 25:3752-3762.
13. Fiaschi-Taesch N., et al. Survey of the human pancreatic beta-cell G1/S proteome reveals a potential therapeutic role for cdk-6 and cyclin D1 in enhancing human beta-cell replication and function in vivo. Diabetes 2009, 58:882-893.
14. Lavine J.A., et al. Contamination with E1A-positive wild-type adenovirus accounts for species-specific stimulation of islet cell proliferation by CCK: a cautionary note. Mol. Endocrinol. 2010, 24:464-467.
15. Fiaschi-Taesch N.M., et al. Induction of human beta-cell proliferation and engraftment using a single G1/S regulatory molecule, cdk6. Diabetes 2010, 59:1926-1936.
16. D'Amour K.A., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24:1392-1401.
17. Kroon E., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008, 26:443-452.
18. Artner I., et al. MafB is required for islet beta cell maturation. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:3853-3858.
19. Artner I., et al. MafA and MafB regulate genes critical to β cells in a unique temporal manner. Diabetes 2010, 59:2530-2539.
20. Nishimura W., et al. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev. Biol. 2006, 293:526-539.
21. Zhou Q., et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008, 455:627-632.
22. Wang H., et al. MAFA controls genes implicated in insulin biosynthesis and secretion. Diabetologia 2007, 50:348-358.
23. Matsuoka T.A., et al. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol. Cell. Biol. 2003, 23:6049-6062.
24. Kataoka K., et al. Differentially expressed Maf family transcription factors, c-Maf and MafA, activate glucagon and insulin gene expression in pancreatic islet alpha- and beta-cells. J. Mol. Endocrinol. 2004, 32:9-20.
25. Artner I., et al. MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. Diabetes 2006, 55:297-304.
26. Gosmain Y., et al. Pax-6 and c-Maf functionally interact with the alpha-cell-specific DNA element G1 in vivo to promote glucagon gene expression. J. Biol. Chem. 2007, 282:35024-35034.
27. Liu Q., et al. Expression of the bZIP transcription factor gene Nrl in the developing nervous system. Oncogene 1996, 12:207-211.
28. Ogino H., Yasuda K. Induction of lens differentiation by activation of a bZIP transcription factor, L-Maf. Science 1998, 280:115-118.
29. Reza H.M., et al. L-Maf, a downstream target of Pax6, is essential for chick lens development. Mech. Dev. 2002, 116:61-73.
30. Takeuchi T., et al. Neither MafA/L-Maf nor MafB is essential for lens development in mice. Genes Cells 2009, 14:941-947.
31. Zhang C., et al. MafA is a key regulator of glucose-stimulated insulin secretion. Mol. Cell. Biol. 2005, 25:4969-4976.
32. Olbrot M., et al. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:6737-6742.
33. Noso S., et al. Insulin transactivator MafA regulates intrathymic expression of insulin and affects susceptibility to type 1 diabetes. Diabetes 2010, 59:2579-2587.
34. Raum J.C., et al. FoxA2, Nkx2. 2, and PDX-1 regulate islet beta-cell-specific mafA expression through conserved sequences located between base pairs -8118 and -7750 upstream from the transcription start site. Mol. Cell. Biol. 2006, 26:5735-5743.
35. Raum J.C., et al. Islet beta-cell-specific MafA transcription requires the 5'-flanking conserved region 3 control domain. Mol. Cell. Biol. 2010, 30:4234-4244.
36. Deol M.S. The abnormalities of the inner ear in kreisler mice. J. Embryol. Exp. Morphol. 1964, 12:475-490.
37. Cordes S.P., Barsh G.S. The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor. Cell 1994, 79:1025-1034.
38. Manzanares M., et al. Segmental regulation of Hoxb-3 by kreisler. Nature 1997, 387:191-195.
39. Sadl V., et al. The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. Dev. Biol. 2002, 249:16-29.
40. Aziz A., et al. MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science 2009, 326:867-871.
41. Aziz A., et al. Development of macrophages with altered actin organization in the absence of MafB. Mol. Cell. Biol. 2006, 26:6808-6818.
42. Sarrazin S., et al. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells. Cell 2009, 138:300-313.
43. Matsuoka T.A., et al. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2930-2933.
44. Pechhold S., et al. Transcriptional analysis of intracytoplasmically stained, FACS-purified cells by high-throughput, quantitative nuclease protection. Nat. Biotechnol. 2009, 27:1038-1042.
45. Aguayo-Mazzucato C., et al. Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells. Diabetologia 2011, 54:583-593.
46. Du A., et al. Islet-1 is required for the maturation, proliferation, and survival of the endocrine pancreas. Diabetes 2009, 58:2059-2069.
47. Gradwohl G. Development of the endocrine pancreas. Diabetes Metab. 2006, 32:532-533.
48. Kim S.K., MacDonald R.J. Signaling and transcriptional control of pancreatic organogenesis. Curr. Opin. Genet. Dev. 2002, 12:540-547.
49. Oliver-Krasinski J.M., Stoffers D.A. On the origin of the beta cell. Genes Dev. 2008, 22:1998-2021.
50. Hamada M., et al. The mouse MafB 5'-upstream fragment directs gene expression in myelomonocytic cells, differentiated macrophages and the ventral spinal cord in transgenic mice. J. Biochem. 2003, 134:203-210.
51. Huang K., et al. Molecular cloning and functional characterization of the mouse MafB gene. Gene 2000, 242:419-426.
52. Offield M.F., et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996, 122:983-995.
53. Ahlgren U., et al. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 1996, 122:1409-1416.
54. Jonsson J., et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994, 371:606-609.
55. Gradwohl G., et al. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1607-1611.
56. Prado C.L., et al. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2924-2929.
57. Nishimura W., et al. Preferential reduction of beta cells derived from Pax6-MafB pathway in MafB deficient mice. Dev. Biol. 2008, 314:443-456.
58. Ashery-Padan R., et al. Conditional inactivation of Pax6 in the pancreas causes early onset of diabetes. Dev. Biol. 2004, 269:479-488.
59. Sander M., et al. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev. 1997, 11:1662-1673.
60. St-Onge L., et al. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 1997, 387:406-409.
61. Naya F.J., et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 1997, 11:2323-2334.
62. Ahlgren U., et al. Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 1998, 12:1763-1768.
63. Gannon M., et al. Pdx-1 function is specifically required in embryonic beta cells to generate appropriate numbers of endocrine cell types and maintain glucose homeostasis. Dev. Biol. 2008, 314:406-417.
64. Kataoka K., et al. MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J. Biol. Chem. 2002, 277:49903-49910.
65. Shieh S.Y., Tsai M.J. Cell-specific and ubiquitous factors are responsible for the enhancer activity of the rat insulin II gene. J. Biol. Chem. 1991, 266:16708-16714.
66. Sharma A., Stein R. Glucose-induced transcription of the insulin gene is mediated by factors required for beta-cell-type-specific expression. Mol. Cell. Biol. 1994, 14:871-879.
67. Vanderford N.L., et al. Glucose induces MafA expression in pancreatic beta cell lines via the hexosamine biosynthetic pathway. J. Biol. Chem. 2007, 282:1577-1584.
68. Artner I., et al. MafA is a dedicated activator of the insulin gene in vivo. J. Endocrinol. 2008, 198:271-279.
69. + cells are islet progenitors and are distinct from duct progenitors. Development 2002, 129:2447-2457.
70. Rocques N., et al. GSK-3-mediated phosphorylation enhances Maf-transforming activity. Mol. Cell 2007, 28:584-597.
71. Guo S., et al. The stability and transactivation potential of the mammalian MafA transcription factor are regulated by serine 65 phosphorylation. J. Biol. Chem. 2009, 284:759-765.
72. Han S.I., et al. MafA stability in pancreatic beta cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3. Mol. Cell. Biol. 2007, 27:6593-6605.
73. Zhao L., et al. The RIPE3b1 activator of the insulin gene is composed of a protein(s) of approximately 43 kDa, whose DNA binding activity is inhibited by protein phosphatase treatment. J. Biol. Chem. 2000, 275:10532-10537.
74. Guo S., et al. Phosphorylation within the MafA N terminus regulates C-terminal dimerization and DNA binding. J. Biol. Chem. 2010, 285:12655-12661.
75. Harmon J.S., et al. Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J. Biol. Chem. 2005, 280:11107-11113.
76. Kitamura Y.I., et al. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005, 2:153-163.
77. Poitout V., et al. Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J. Clin. Invest. 1996, 97:1041-1046.
78. Sharma A., et al. The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol. Endocrinol. 1995, 9:1127-1134.
79. Matsuoka T.A., et al. Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes. Diabetes 2010, 59:1709-1720.
80. Olson L.K., et al. Reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9127-9131.
81. Harmon J.S., et al. Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity. Diabetes 1998, 47:900-904.
82. Hagman D.K., et al. Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J. Biol. Chem. 2005, 280:32413-32418.
83. Harmon J.S., et al. beta-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice. Endocrinology 2009, 150:4855-4862.
84. Lenzen S., et al. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 1996, 20:463-466.
85. Tiedge M., et al. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997, 46:1733-1742.
86. Kondo T., et al. p38 MAPK is a major regulator of MafA protein stability under oxidative stress. Mol. Endocrinol. 2009, 23:1281-1290.
87. Yamamoto M., et al. Transgenic expression of antioxidant protein thioredoxin in pancreatic beta cells prevents progression of type 2 diabetes mellitus. Antioxid. Redox Signal. 2008, 10:43-49.
88. Gupta R.K., et al. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha. Genes Dev. 2007, 21:756-769.
89. Karnik S.K., et al. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 2007, 318:806-809.
90. Zhang H., et al. Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen. Diabetes 2010, 59:143-152.
91. Oetjen E., et al. Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1beta and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells. Diabetologia 2007, 50:1678-1687.
92. Ortis F., et al. Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells. Diabetes 2010, 59:358-374.
93. Eychene A., et al. A new MAFia in cancer. Nat. Rev. Cancer 2008, 8:683-693.
94. Nishizawa M., et al. v-Maf, a viral oncogene that encodes a 'leucine zipper' motif. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:7711-7715.
95. Coolen M., et al. Phylogenomic analysis and expression patterns of large Maf genes in Xenopus tropicalis provide new insights into the functional evolution of the gene family in Osteichthyans. Dev. Genes Evol. 2005, 215:327-339.
96. Blank V., Andrews N.C. The Maf transcription factors: regulators of differentiation. Trends Biochem. Sci. 1997, 22:437-441.
97. Kataoka K., et al. Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family. J. Virol. 1993, 67:2133-2141.
98. Kerppola T.K., Curran T. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins. Oncogene 1994, 9:3149-3158.
99. Yoshida T., et al. The 5'-AT-rich half-site of Maf recognition element: a functional target for bZIP transcription factor Maf. Nucleic Acids Res. 2005, 33:3465-3478.
100. Motohashi H., et al. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 2002, 294:1-12.
101. Kataoka K., et al. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins. Oncogene 1996, 12:53-62.
102. Blank V. Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?. J. Mol. Biol. 2008, 376:913-925.
103. Kataoka K. Multiple mechanisms and functions of maf transcription factors in the regulation of tissue-specific genes. J. Biochem. 2007, 141:775-781.
104. Murakami Y.I., et al. c-Maf expression in angioimmunoblastic T-cell lymphoma. Am. J. Surg. Pathol. 2007, 31:1695-1702.
105. Chang H., et al. c-Maf nuclear oncoprotein is frequently expressed in multiple myeloma. Leukemia 2007, 21:1572-1574.
106. Hurt E.M., et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell 2004, 5:191-199.
107. van Stralen E., et al. Identification of primary MAFB target genes in multiple myeloma. Exp. Hematol. 2009, 37:78-86.
108. Rutter W.J., et al. Regulation of specific protein synthesis in cytodifferentiation. J. Cell. Physiol. 1968, 72(Suppl. 1):1-18.
109. Pictet R.L., et al. An ultrastructural analysis of the developing embryonic pancreas. Dev. Biol. 1972, 29:436-467.
110. Pang K., et al. Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of the developing rat pancreas. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:9559-9563.
111. Slack J.M. Developmental biology of the pancreas. Development 1995, 121:1569-1580.
112. Han J.H., et al. Selective expression of rat pancreatic genes during embryonic development. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:110-114.
113. Espinosa de los M., et al. Insulin release from isolated human fetal pancreatic islets. Science 1970, 168:1111-1112.
114. Heinze E., Steinke J. Insulin secretion during development: response of isolated pancreatic islets of fetal, newborn and adult rats to theophylline and arginine. Horm. Metab. Res. 1972, 4:234-236.
115. Norlin S., et al. Nuclear factor-κB activity in β-cells is required for glucose-stimulated insulin secretion. Diabetes 2005, 54:125-132.
116. Chen C., et al. Characterization of an in vitro differentiation assay for pancreatic-like cell development from murine embryonic stem cells: detailed gene expression analysis. Assay Drug Dev. Technol. 2011, 10.1089/adt.2010.0314.
117. Chiou S.H., et al. MafA promotes the reprogramming of placenta-derived multipotent stem cells into pancreatic islets-like and insulin-positve cells. J. Cell. Mol. Med. 2010, 15:612-624.
118. Ogihara T., et al. Combined expression of transcription factors induces AR42J-B13 cells to differentiate into insulin-producing cells. Endocr. J. 2008, 55:691-698.
119. Song Y.D., et al. Islet cell differentiation in liver by combinatorial expression of transcription factors neurogenin-3, BETA2, and RIPE3b1. Biochem. Biophys. Res. Commun. 2007, 354:334-339.
120. Nomura S., et al. MafA differentiates rat intestinal cells into insulin-producing cells. Biochem. Biophys. Res. Commun. 2006, 349:136-143.